Breaking Down Ushio Inc. Financial Health: Key Insights for Investors

Curious whether Ushio Inc. (6925.T) is a value play or a turnaround story? The company reported fiscal 2025 revenue of ¥177.62 billion (down 1.01% YoY) with TTM revenue at ¥173.40 billion (a 3.70% YoY decline) and a Q2 FY2025 quarterly drop to ¥43.07 billion (‑10.47% QoQ), yet management kept its consolidated earnings forecast intact - while underlying metrics show mixed signals: a net cash position of ¥13.95 billion, strong liquidity (current ratio 2.51, cash and equivalents ¥67.03 billion), modest margins (gross ~35%, operating 4.94%, net 3.8%), and a lofty trailing P/E of 46.28 versus a forward P/E of 23.41; balance sheet strength is evident (debt-to-equity 0.31, equity ratio ~67.5%), but the Altman Z-Score at 2.56 and planned ¥3.1 billion restructuring costs for Q1 FY2026 raise caution - read on for a data-driven breakdown of profitability, liquidity, valuation, risks and the growth assumptions underpinning analyst forecasts of ~37.6% annual earnings growth and 8.4% revenue CAGR.

Ushio Inc. (6925.T) - Revenue Analysis

• FY ending Mar 31, 2025 revenue: ¥177.62 billion (-1.01% YoY)
• TTM revenue as of Sep 30, 2025: ¥173.40 billion (-3.70% YoY)
• Q2 FY2025 (quarter ended Sep 30, 2025): ¥43.07 billion (-10.47% QoQ YoY)
• Consolidated earnings forecast: maintained for FY ending Mar 2025

• Operational efficiency signal: ~¥28.84 million revenue per employee suggests moderate productivity relative to industry peers.
• Valuation context: P/S of 1.16 places Ushio at a market valuation modestly above one year of sales.
• Short-term trend: Q2 contraction and declining TTM revenue point to near-term headwinds; maintained earnings forecast implies confidence in cost controls or non-revenue drivers.

Ushio Inc. (6925.T) - Profitability Metrics

• Gross margin (~35%) signals product-level resilience and pricing power in core lines.
• EBITDA margin (9.73%) indicates the business can generate solid operating cash earnings before D&A and financial costs.
• Lower operating (4.94%) and net margins (3.8%) point to pressure from SG&A, depreciation, interest, or taxes that compress net returns.
• ROE (2.33%) and ROA (1.73%) are subdued, implying returns are modest relative to capital and asset base.

Ushio Inc. (6925.T) - Debt vs. Equity Structure

• Low leverage: Debt-to-equity of 0.31 indicates a conservative use of debt versus equity financing.
• Strong equity buffer: Equity ratio ~67.5% reduces solvency risk and supports creditor confidence.
• Manageable gross indebtedness: Total debt of ¥41.17B against liabilities of ¥96.05B suggests limited leverage relative to obligations.
• Positive liquidity: Net cash of ¥13.95B (cash minus debt) provides a cushion for capex, M&A, or downturns.
• High interest coverage: 27.65x coverage shows operating income comfortably covers interest expenses.
• Credit distress signal context: Altman Z-Score of 2.56 sits below the traditional ">3" safety threshold but generally indicates low near-term bankruptcy risk when combined with strong interest coverage and net cash.

• Balance-sheet strength supports dividend sustainability and strategic investment without urgent refinancing need.
• Lower financial risk enhances ability to pursue selective leverage for growth while maintaining credit flexibility.
• Monitor Z-Score trajectories and any shifts in operating income that could affect interest coverage despite current strong metrics.

Ushio Inc. (6925.T) - Liquidity and Solvency

• Current ratio: 2.51 - comfortably above 1, indicating ample short-term asset coverage of liabilities.
• Quick ratio: 1.40 - sufficient immediate liquidity excluding inventories.
• Cash and cash equivalents (as of Sept 30, 2025): ¥67.03 billion - a substantial liquidity buffer.
• Free cash flow (TTM): ¥6.78 billion - positive cash generation after capex.
• Operating cash flow to net income ratio: 3.0 - strong cash generation relative to accounting profit.
• Net cash per share: ¥168.88 - meaningful per-share cash cushion.

Ushio Inc. (6925.T) - Valuation Analysis

• Trailing P/E: 46.28 - indicates investors are paying a high multiple for the most recent 12 months of earnings.
• Forward P/E: 23.41 - market-implied improvement in earnings or lower near-term valuation compared with trailing.
• Price-to-Book (P/B): 1.07 - equity valued marginally above stated book value.
• EV/EBITDA: 11.09 - moderate valuation against operating cash profits before non-cash charges.
• EV/FCF: 15.02 - investors pay a premium relative to free cash flow generation.

• Relative context: A trailing P/E of 46.28 versus forward P/E of 23.41 implies the market expects material earnings improvement or normalization of one-off factors that depressed recent earnings.
• Capital structure: EV (¥187.13B) slightly below market cap (¥201.07B) suggests net cash or low net debt position contributing to shareholder value.
• Value vs. fundamentals: P/B ~1.07 signals limited premium to book, while EV/EBITDA ~11 and EV/FCF ~15 show a moderate premium for cash generation and operational profitability.

Ushio Inc. (6925.T) - Risk Factors

Key financial and operational risk indicators for Ushio Inc. (6925.T) highlight restructuring costs, recent profit declines, stagnant revenue, cash-flow volatility, and moderate credit/quality scores. Investors should weigh the following specific datapoints and implications.

• Extraordinary restructuring charges: planned Q1 FY2026 one-off costs of approximately ¥3.1 billion (severance and outplacement).
• Sharp earnings deterioration in Q1 FY2025 vs prior year: net sales down 4.4%; operating profit down 83.3%; profit attributable to owners down 83.4%.
• Revenue trend: near-flat to slightly negative - overall revenue down about 1% year-on-year (stagnation risk).
• Cash-flow volatility: free cash flow swung to a positive ¥6.78 billion after prior negative periods - indicating inconsistent cash generation.
• Altman Z-Score: 2.56 - below 3.0 (signals potential financial distress despite relatively low immediate bankruptcy risk).
• Piotroski F-Score: 6 - moderate financial strength (scores ≥7 typically indicate stronger fundamentals).

• Operational risks: restructuring may disrupt operations and reduce near-term productivity while charges depress EPS.
• Market growth risk: stagnant revenue growth raises reliance on cost-cutting or M&A to drive future earnings.
• Liquidity and solvency watch: positive FCF is encouraging but the Altman score under 3 and past negative cash flows warrant monitoring of liquidity measures and debt maturities.
• Execution risk: achieving post-restructuring synergies and regaining margin stability is uncertain and critical for restoring investor confidence.

For further context on shareholder base and investor activity around Ushio Inc., see: Exploring Ushio Inc. Investor Profile: Who's Buying and Why?

Ushio Inc. (6925.T) - Growth Opportunities

• Analysts forecast earnings growth of 37.6% per annum, implying rapid profit expansion if targets and cost programs hold.
• Revenue is projected to grow at 8.4% per annum, supporting top‑line expansion through product mix improvement and market penetration.
• Return on equity is expected to reach ~6% within three years, indicating gradual restoration of shareholder returns as margins recover.

• Extraordinary income from planned investment securities sales can materially improve liquidity and provide capital for R&D or debt reduction; timing and net proceeds are critical to quantify impact.
• Restructuring and cost‑cutting can accelerate margin recovery-if executed without impairing revenue growth-enhancing operating leverage on the forecasted 8.4% top‑line expansion.
• Focused innovation in light solutions and photonics positions Ushio to capture higher‑margin opportunities in industrial, medical and semiconductor tooling markets.

• Monitor: quarterly progress on the sale of investment securities (size/timing), restructuring milestones, and product pipeline commercialization.
• Validate: whether the 37.6% EPS CAGR is driven by recurring operations or inflated by one‑time gains; separate operating EPS from extraordinary items.
• Stress test: sensitivities to slower revenue growth (below 8.4%) and delayed cost savings-assess impact on the path to 6% ROE.